Report overview
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
This report contains market size and forecasts of Prostate Cancer Biomarker in Global, including the following market information:
Global Prostate Cancer Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Cancer Biomarker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Urine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Biomarker include Thermo Fisher Scientific, QIAGEN, Roche Diagnostics, Beckman Coulter, Myriad Genetics, Sanofi-Aventis, Pfizer and MDx Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Biomarker Market Segment Percentages, by Type, 2021 (%)
Urine
Blood
Serum
Global Prostate Cancer Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Biomarker Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Cancer Institutes
Global Prostate Cancer Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Cancer Biomarker Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Cancer Biomarker revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
QIAGEN
Roche Diagnostics
Beckman Coulter
Myriad Genetics
Sanofi-Aventis
Pfizer
MDx Health
